BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37245629)

  • 1. Clinicopathologic characterization of hepatocellular adenomas in men: a multicenter experience.
    González IA; Torbenson M; Sharifai N; Byrnes K; Chatterjee D; Kakar S; Yeh MM; Wu TT; Zhang X; Jain D
    Hum Pathol; 2023 Aug; 138():24-33. PubMed ID: 37245629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular Adenoma Subtypes Based on 2017 Classification System: Exploratory Study of Gadoxetate Disodium-Enhanced MRI Features With Proposal of a Diagnostic Algorithm.
    Tse JR; Felker ER; Cao JJ; Naini BV; Liang T; Lu DSK; Raman SS
    AJR Am J Roentgenol; 2023 Apr; 220(4):539-550. PubMed ID: 36169546
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatocellular adenomas in the Turkish population: reclassification according to updated World Health Organization criteria.
    Deniz K; Umetsu SE; Ferrell L; Yılmaz F; Güllüoğlu M; Sağol Ö; Doğusoy GB; Kırımlıoğlu H; Turhan N; Doran F; Kepil N; Çelikel ÇA; Nart D; Özgüven BY; Ceyran B; Karadağ N; Kır G; Erden E; Yılmaz G; Akyol G
    Histopathology; 2021 Jul; 79(1):23-33. PubMed ID: 33406290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I.
    Calderaro J; Labrune P; Morcrette G; Rebouissou S; Franco D; Prévot S; Quaglia A; Bedossa P; Libbrecht L; Terracciano L; Smit GP; Bioulac-Sage P; Zucman-Rossi J
    J Hepatol; 2013 Feb; 58(2):350-7. PubMed ID: 23046672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up.
    Shafizadeh N; Genrich G; Ferrell L; Kakar S
    Hum Pathol; 2014 May; 45(5):976-83. PubMed ID: 24746201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular adenomas: review of pathological and molecular features.
    Beaufrère A; Paradis V
    Hum Pathol; 2021 Jun; 112():128-137. PubMed ID: 33307077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.
    Nault JC; Couchy G; Balabaud C; Morcrette G; Caruso S; Blanc JF; Bacq Y; Calderaro J; Paradis V; Ramos J; Scoazec JY; Gnemmi V; Sturm N; Guettier C; Fabre M; Savier E; Chiche L; Labrune P; Selves J; Wendum D; Pilati C; Laurent A; De Muret A; Le Bail B; Rebouissou S; Imbeaud S; ; Bioulac-Sage P; Letouzé E; Zucman-Rossi J
    Gastroenterology; 2017 Mar; 152(4):880-894.e6. PubMed ID: 27939373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes following resection of hepatocellular adenomas with small foci of malignant transformation or malignant adenomas.
    Chopinet S; Cauchy F; Hobeika C; Beaufrère A; Poté N; Farges O; Dokmak S; Bouattour M; Ronot M; Vilgrain V; Paradis V; Soubrane O
    JHEP Rep; 2021 Aug; 3(4):100326. PubMed ID: 34368664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience.
    Bioulac-Sage P; Laumonier H; Couchy G; Le Bail B; Sa Cunha A; Rullier A; Laurent C; Blanc JF; Cubel G; Trillaud H; Zucman-Rossi J; Balabaud C; Saric J
    Hepatology; 2009 Aug; 50(2):481-9. PubMed ID: 19585623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis.
    Margolskee E; Bao F; de Gonzalez AK; Moreira RK; Lagana S; Sireci AN; Sepulveda AR; Remotti H; Lefkowitch JH; Salomao M
    Diagn Pathol; 2016 Mar; 11():27. PubMed ID: 26961851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applying criteria for hepatocellular neoplasm of uncertain malignant potential reclassifies more than half of hepatocellular adenomas.
    Larson BK; Guindi M
    Ann Diagn Pathol; 2021 Dec; 55():151833. PubMed ID: 34597957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Argininosuccinate synthase 1 (ASS1): A marker of unclassified hepatocellular adenoma and high bleeding risk.
    Henriet E; Abou Hammoud A; Dupuy JW; Dartigues B; Ezzoukry Z; Dugot-Senant N; Leste-Lasserre T; Pallares-Lupon N; Nikolski M; Le Bail B; Blanc JF; Balabaud C; Bioulac-Sage P; Raymond AA; Saltel F
    Hepatology; 2017 Dec; 66(6):2016-2028. PubMed ID: 28646562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular adenoma management: call for shared guidelines and multidisciplinary approach.
    Blanc JF; Frulio N; Chiche L; Sempoux C; Annet L; Hubert C; Gouw AS; de Jong KP; Bioulac-Sage P; Balabaud C
    Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):180-7. PubMed ID: 25434466
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Longerich T; Endris V; Neumann O; Rempel E; Kirchner M; Abadi Z; Uhrig S; Kriegsmann M; Weiss KH; Breuhahn K; Mehrabi A; Weber TF; Wilkens L; Straub BK; Rosenwald A; Schulze F; Brors B; Froehling S; Pellegrino R; Budczies J; Schirmacher P; Stenzinger A
    Gut; 2019 Jul; 68(7):1287-1296. PubMed ID: 30901310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and epigenetic analysis of hepatocellular adenomas with atypical morphological features.
    Haefliger S; Hench J; O'Rourke CJ; Meyer-Schaller N; Uzun S; Saldarriaga J; Weber A; Mazzucchelli L; Jermann P; Frank S; Andersen JB; Terracciano L; Sempoux C; Matter MS
    Histopathology; 2023 Apr; 82(5):722-730. PubMed ID: 36583256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing trends in malignant transformation of hepatocellular adenoma.
    Farges O; Ferreira N; Dokmak S; Belghiti J; Bedossa P; Paradis V
    Gut; 2011 Jan; 60(1):85-9. PubMed ID: 21148580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular Adenoma: Report of 2 Cases That Highlight the Relevance of Phenotype-Genotype Correlation in the Pediatric Population.
    Jiao J; Finberg KE; Jain D; Morotti R
    Pediatr Dev Pathol; 2023; 26(4):394-403. PubMed ID: 37334553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular adenoma in men: A nationwide assessment of pathology and correlation with clinical course.
    van Rosmalen BV; Furumaya A; Klompenhouwer AJ; Tushuizen ME; Braat AE; Reinten RJ; Ligthart MAP; Haring MPD; de Meijer VE; van Voorthuizen T; Takkenberg RB; Dejong CHC; de Man RA; IJzermans JNM; Doukas M; van Gulik TM; Verheij J;
    Liver Int; 2021 Oct; 41(10):2474-2484. PubMed ID: 34155783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of contrast-enhanced ultrasound features of hepatocellular adenoma according to different pathological molecular classifications.
    Chen K; Dong Y; Zhang W; Han H; Mao F; Zhang Q; Zheng Z; He W; Wang WP
    Clin Hemorheol Microcirc; 2020; 76(3):391-403. PubMed ID: 32675402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New MRI features improve subtype classification of hepatocellular adenoma.
    Bise S; Frulio N; Hocquelet A; Alberti N; Blanc JF; Laurent C; Laumonier H; Balabaud C; Bioulac-Sage P; Trillaud H
    Eur Radiol; 2019 May; 29(5):2436-2447. PubMed ID: 30523457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.